hsg logo white

Mission & Vision

The Huntington Study Group (HSG), which was formed in 1993, is the world’s first HD cooperative therapeutic research organization. Today, HSG is a world leader in facilitating high quality clinical research trials and studies that bring us closer to accelerating more effective treatments for HD and reducing the burden of HD for families impacted by the disease.

HSG is an organization of compassionate professionals dedicated to accelerating treatments that make a difference, providing rigorous care initiatives, and improving the quality of life and outcomes for HD families. We bring together families, medical professionals, clinical researchers, HD advocacy groups, and sponsors to raise awareness of HD, share knowledge and best practices, and develop innovative treatments.

hsg circle logo


Mission: To accelerate treatments that make a difference for Huntington’s disease.

Vision: To improve the lives of people impacted by HD through research, education, and collaboration.


Vision: To be the world-leading clinical research organization for the design and execution of trials for HD and other therapeutic areas within our strategic focus.

HSG conducts clinical trials through its wholly owned subsidiary, HSG Clinical Research, Inc. (HSGCR).